Anti-CD20-and B-cell receptor-mediated apoptosis: Evidence for shared intracellular signaling pathways

Cancer Research

Volumn 60, Issue 24, 2000, Pages 7170-7176

  Mathas, S ^a   Rickers, A ^a   Bommert, K ^a   Dorken B ^a   Mapara, M Y ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD20 ANTIGEN; IMMUNOGLOBULIN M; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; PROTEIN BAK; PROTEIN P44; RITUXIMAB; TRANSCRIPTION FACTOR AP 1;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER REGRESSION; CARCINOGENESIS; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CORRELATION FUNCTION; DNA BINDING; EARLY RESPONSE GENE; ENZYME ACTIVATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; ONCOGENE C MYC; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANTIGENS, CD20; APOPTOSIS; B-LYMPHOCYTES; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, NORTHERN; BURKITT LYMPHOMA; BUTYRATE RESPONSE FACTOR 1; CASPASES; CELL DIVISION; CELL NUCLEUS; DNA; DNA-BINDING PROTEINS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOBLOTTING; IMMUNOGLOBULIN M; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ANTIGEN, B-CELL; RNA; RNA, MESSENGER; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0034671315     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Ontogeny of human hematopoietic cells: Analysis utilizing monoclonal antibodies
2. 2+ conductance found constitutively in B lymphocytes
3. 1 phase of the cell cycle
4. CD20: A regulator of cell-cycle progression of B lymphocytes
5. Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes
6. Association of 75/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B cell molecule CD20. Evidence against involvement of the cytoplasmic regions of CD20
7. Association of tyrosine and serine kinases with the B cell surface antigen CD20. Induction via CD20 of tyrosine phosphorylation and activation of phospholipase C-γ 1 and PLC phospholipase C-γ 2
8. Expression of human B cell-associated antigens on leukemias and lymphomas: A model of human B cell differentiation
9. Monoclonal antibody IF5 (anti-CD20) serotherapy of human lymphomas
10. Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue
11. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma
12. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
13. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program
14. IDEC-C2B8: Results of a Phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma
15. Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies
16. A new human B-cell non-Hodgkin's lymphoma cell line (Karpas 422) exhibiting both t(14;18) and t(4;11) chromosomal translocations
17. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation
18. The Bcl-2 protein family: Arbiters of cell survival
19. Caspases: Killer proteases
20. L in CD40-mediated rescue from anti-μ-induced apoptosis in WEHI-231 B lymphoma cells
21. Overexpression of the death-promoting gene bax-α sensitizes human BL-41 Burkitt lymphoma cells for surface IgM-mediated apoptosis
22. Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis
23. From receptors to stress-activated MAP kinases
24. Convergence of CD19 and B cell antigen receptor signals at MEK1 in the ERK2 activation cascade
25. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor
26. CD22 cross-linking generates B-cell antigen receptor-independent signals that activate the JNK/SAPK signaling cascade
27. Positive versus negative signaling by lymphocyte antigen receptors
28. Involvement of NAK-1, the human nur77 homologue, in surface IgM-mediated apoptosis in Burkitt lymphoma cell line BL41
29. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells
30. 12-O-Tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region
31. Anti-1gM-mediated regulation of c-myc and its possible relationship to apoptosis
32. Distinct mechanisms for rescue from apoptosis in Ramos human B ceils by signaling through CD40 and interleukin-4 receptor: Role for inhibition of an early response gene, Berg36
33. Receptor-specific induction of individual AP-l components in B lymphocytes
34. Monoclonal antibody therapy of B cell lymphoma: Signaling activity on tumor cells appears more important than recruitment of effectors
35. Growth inhibition of CD20-positive B lymphoma cell lines by IDEC-C2B8 anti-CD20 monoclonal antibody
36. Inhibitory Fc receptors modulate in viva cytotoxicity against tumor targets
37. Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells
38. Cleavage of poly(ADP-ribose) polymerase by a preteinase with properties like ICE
39. Induction of Bax-α precedes apoptosis in a human B lymphoma cell line: Potential role of the bcl-2 gene family in surface IgM-mediated apoptosis
40. Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: A British National Lymphoma Investigation Study
41. bcl-2 Gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs
42. Overexpression of the death-promoting gene bax-α which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice
43. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance
44. The association between CD20 and Src-family tyrosine kinases requires an additional factor
45. Molecular mechanisms in B cell antigen receptor signaling
46. Activation of dense human tonsilar B-cells
47. 2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor
48. Genetic analysis of B cell antigen receptor signaling
49. 2-terminal kinase 1, and p38 mitogen-activated protein kinase
50. Cross-linking of surface lgM stimulates the Ras/Raf-1/MEK/MAPK cascade in human B lymphocytes
51. Selective activation of p42 mitogen-activated protein (MAP) kinase in murine B lymphoma cell lines by membrane immunoglobulin cross-linking. Evidence for protein kinase C-independent and -dependent mechanisms of activation